Citations

Clear

7551 citation(s) found for "Ho, Matthew".

Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma
Jaïs, Jean‐Philippe , Ghesquières, Hervé , Thompson, Carrie A. , Thiéblemont, Catherine , Micallef, Ivana N. , Porrata, Luis F. , Nowakowski, G. S., Casasnovas, Olivier , Bologna, Serge, Morrison, Vicki A., Macon, William R. , Copie‐Bergman, Christiane , Feldman, Andrew L. , Syrbu, Sergei , Kurtin, Paul J. , Gascoyne, Randy D. , Li, Hailun , Allmer, Cristine, Ansell, Stephen M. , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Nowakowski, Gregorz S, Maurer, Matthew J. , Witzig, Thomas E. , Hong, Fangxin , Haïoun, Corinne , Ribrag, Vincent , Morschhauser, Franck , Peterson, Bruce A. , Kahl, Brad S. , Slager, Susan L. , Habermann, Thomas M. , Cerhan, James R. , Feldman, Andrew L , Link, Brian K , Salles, Gilles A , Syrbu, Sergei , Casasnovas, René-Olivier

Mayo Clinic

American Journal of Hematology | October 22, 2015 | Volume: 91 | Issue: 2 | Pages: 179-184

10.1002/ajh.24223 | PMID 26492520 Get It

We recently defined event‐free survival at 24 months (EFS24) as a clinically relevant outcome for patients with DLBCL. Patients who fail EFS24 have very poor overall survival, while those who achieve EFS24 have a subsequent overall survival equivalent to that of the age‐ and sex‐matched general population. Here, we develop and validate a clinical risk calculator (IPI24) for EFS24. Model building was performed on a discovery dataset of 1,348 patients with DLBCL and treated with anthracycline‐based immunochemotherapy. A multivariable model containing age, Ann Arbor stage, normalized serum LDH, ALC, ECOG performance status, bulky disease, and sex was identified. The model was then applied to an independent validation dataset of 1,177 DLBCL patients. The IPI24 score estimates the probability of failing to achieve the EFS24 endpoint for an individual patient. The IPI24 model showed superior discriminatory ability (c‐statistic = 0.671) in the validation dataset compared to the IPI (c‐statistic = 0.649) or the NCCN‐IPI (c‐statistic = 0.657). After recalibration of the model on the combined dataset, the median predicted probability of failing to achieve EFS24 was 36% (range, 12–88%), and the IPI24 showed an EFS24 gradient in all IPI groups. The IPI24 also identified a significant percentage of patients with high risk disease, with over 20% of patients having a 50% or higher risk of failing to achieve EFS24. The IPI24 provides an individual patient level probability of achieving the clinically relevant EFS24 endpoint. It can be used via electronic apps. Am. J. Hematol. 91:179–184, 2016. © 2015 Wiley Periodicals, Inc.
Posterolateral Reconstruction of the Knee: Two-Tailed Surgical Techniques
Prince, Matthew, King, Alexander H. , Sousa, Paul L., Levy, Bruce A. , Prince, Matthew R, Stuart, Michael J.

Mayo Clinic

Journal of Knee Surgery | October 19, 2015 | Volume: 28 | Issue: 06 | Pages: 464-470

10.1055/s-0035-1559579 | PMID 26480347 Get It

MDS research criteria for prodromal Parkinson's disease
Berg, Daniela , Bloem, Bastiaan R. , Dubois, Bruno, Gasser, Thomas , Halliday, Glenda M. , Joseph, Lawrence , Lang, Anthony E. , Liepelt‐Scarfone, Inga , Litvan, Irene , Marek, Kenneth , Oertel, Wolfgang H. , Olanow, C. Warren , Deuschl, Günther , Postuma, Ronald B. , Adler, Charles H. , Chan, Piu , Goetz, Christopher G. , Obeso, Jose Angel , Poewe, Werner H , Stern, Matthew , Halliday, Glenda , Lang, Anthony E , Deuschl, Günther , Litvan, Irene

Mayo Clinic

Movement Disorders | October 16, 2015 | Volume: 30 | Issue: 12 | Pages: 1600-1611

10.1002/mds.26431 | PMID 26474317 Get It

ABSTRACT This article describes research criteria and probability methodology for the diagnosis of prodromal PD. Prodromal disease refers to the stage wherein early symptoms or signs of PD neurodegeneration are present, but classic clinical diagnosis based on fully evolved motor parkinsonism is not yet possible. Given the lack of clear neuroprotective/disease‐modifying therapy for prodromal PD, these criteria were developed for research purposes only. The criteria are based upon the likelihood of prodromal disease being present with probable prodromal PD defined as ≥80% certainty. Certainty estimates rely upon calculation of an individual's risk of having prodromal PD, using a Bayesian naïve classifier. In this methodology, a previous probability of prodromal disease is delineated based upon age. Then, the probability of prodromal PD is calculated by adding diagnostic information, expressed as likelihood ratios. This diagnostic information combines estimates of background risk (from environmental risk factors and genetic findings) and results of diagnostic marker testing. In order to be included, diagnostic markers had to have prospective evidence documenting ability to predict clinical PD. They include motor and nonmotor clinical symptoms, clinical signs, and ancillary diagnostic tests. These criteria represent a first step in the formal delineation of early stages of PD and will require constant updating as more information becomes available. © 2015 International Parkinson and Movement Disorder Society
MDS clinical diagnostic criteria for Parkinson's disease
Berg, Daniela , Olanow, C. Warren , Oertel, Wolfgang H. , Marek, Kenneth , Litvan, Irene , Lang, Anthony E. , Halliday, Glenda M. , Gasser, Thomas , Dubois, Bruno, Bloem, Bastiaan R. , Deuschl, Günther , Postuma, Ronald B. , Stern, Matthew , Poewe, Werner H , Obeso, Jose Angel , Goetz, Christopher G. , Chan, Piu , Adler, Charles H. , Halliday, Glenda , Lang, Anthony E , Deuschl, Günther , Litvan, Irene

Mayo Clinic

Movement Disorders | October 16, 2015 | Volume: 30 | Issue: 12 | Pages: 1591-1601

10.1002/mds.26424 | PMID 26474316 Get It

AbstractThis document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities remain central, increasing recognition has been given to nonmotor manifestations; these are incorporated into both the current criteria and particularly into separate criteria for prodromal PD. Similar to previous criteria, the Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity. Explicit instructions for defining these cardinal features are included. After documentation of parkinsonism, determination of PD as the cause of parkinsonism relies on three categories of diagnostic features: absolute exclusion criteria (which rule out PD), red flags (which must be counterbalanced by additional supportive criteria to allow diagnosis of PD), and supportive criteria (positive features that increase confidence of the PD diagnosis). Two levels of certainty are delineated: clinically established PD (maximizing specificity at the expense of reduced sensitivity) and probable PD (which balances sensitivity and specificity). The Movement Disorder Society criteria retain elements proven valuable in previous criteria and omit aspects that are no longer justified, thereby encapsulating diagnosis according to current knowledge. As understanding of PD expands, the Movement Disorder Society criteria will need continuous revision to accommodate these advances. © 2015 International Parkinson and Movement Disorder Society
Surgical management of lateral skull base defects
Patel, Neil , Modest, Mara C., Brobst, Tyler D. , Carlson, Matthew L. , Moore, Eric J. , Janus, Jeffrey R. , Price, Daniel L.

Mayo Clinic

The Laryngoscope | October 15, 2015 | Volume: 126 | Issue: 8 | Pages: 1911-1917

10.1002/lary.25717 | PMID 26466854 Get It

Objectives/HypothesisWe sought to analyze key factors that influence the management of lateral skull base defects and implement an algorithm to improve outcomes of reconstruction.Study DesignRetrospective chart review.SettingSingle tertiary academic referral center.MethodsAdults who underwent temporal bone resection were included. Variables included tumor characteristics, ablative procedure, reconstructive method, and wound complications.ResultsSeventy‐one patients were studied. Lateral temporal bone resection was performed in 55 patients (77%), subtotal temporal bone resection in 14 (20%), and total petrosectomy in two (3%). Primary closure was achieved in 46 patients (35%), with rotational muscle flaps in 21 (46%). The pectoralis major myocutaneous flap (PMMF) was used in nine patients (13%) without major complications. Single‐stage free tissue transfer was undertaken in 10 patients (14%) with no flap failures. Primary closure was achieved in 16 of 32 of previously untreated cases (50%) compared to nine of 39 cases of previously treated disease (23%) (P = 0.03). Pedicled or free flaps were used in 18 of 39 cases of previously treated disease (46%) compared to three of 32 previously untreated cases (9%) (P < 0.001). Pedicled or free flaps were used in 13 of 22 cases (59%) in which partial or total auriculectomy was performed, whereas primary closure was achieved in 39 of 49 cases (80%) in which the pinna was preserved (P < 0.001).ConclusionAdvanced tumors that require adjuvant therapy, revision cases for recurrent disease, and cases involving auriculectomy warrant free flap or PMMF reconstruction, with the latter preferred in poor free flap candidates.Level of Evidence4. Laryngoscope, 126:1911–1917, 2016
Viscosity-compensated shear speed imaging with acoustic radiation force
Yang, Yiqun , McGough, Robert J., Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | October 14, 2015 | Volume: 138 | Issue: 3_Supplement | Pages: 1907-1907

10.1121/1.4933996 Get It

Shear wave elastography imaging (SWEI) with ultrasound uses an applied acoustic radiation force to obtain quantitative images of liver, breast, prostate, and other soft tissues. In SWEI, shear velocity waveforms are collected along a line, and then, the shear speed is estimated either with a k-space or a correlation-based method. Although these yield effective estimates in elastic media, both methods consistently overestimate the shear speed in viscoelastic soft tissue because neither considers the shear viscosity. To address this problem, we have created a new shear speed estimation approach that also accounts for the effect of shear viscosity. The new approach is evaluated in a computational model that calculates the three-dimensional (3D) intensity field generated by a linear array transducer in FOCUS (http://www.egr.msu.edu/~fultras-web) and then simulates the shear wave velocities in a viscoelastic medium with a 3D finite difference model. In the viscoelastic shear wave simulation model, the shear speed constant is 1.5 m/s, and the shear viscosity is 1 Pa·s. Correlation-based shear speed estimates are compared to the viscosity-compensated estimates, and the results show that the viscosity-compensated approach consistently achieves improved shear speed estimates relative to the correlation-based method. [Work supported in part by NIH Grant Nos. R01EB012079 and R01DK092255.]
Simulation of wave propagation in anisotropic and viscoelastic tissues
Qiang, Bo, Aristizabal, Sara , Nenadic, Ivan , McGough, Robert J., Greenleaf, James F. , Urban, Matthew W. , Song, Pengfei , Chen, Shigao

Mayo Clinic

The Journal of the Acoustical Society of America | October 14, 2015 | Volume: 138 | Issue: 3_Supplement | Pages: 1906-1906

10.1121/1.4933994 Get It

Many methods for characterization of the mechanical properties of soft tissues using propagating shear waves have been developed over the past two decades. Most of these methods assume that the shear wave is traveling in an elastic, isotropic tissue. However, many soft tissues are viscoelastic and have material properties that are directionally dependent or anisotropic. We have been developing methods to measure waves propagating in soft tissues to estimate the anisotropic viscoelastic material properties. To refine our measurement methods, we have also developed techniques and models for simulating the wave propagation in these types of materials. We have developed specialized finite element and pseudo-spectral models that can simulate viscoelastic transversely isotropic materials and compared our results with measurements in ex vivo porcine muscle. Additionally, we have developed a finite element model that simulates wave propagation in the myocardium by creating a model of layered transverse isotropic media oriented at different angles. We examined the effect of frequency of the waves for estimating of the angle of propagation. We compared these simulation results with experimental results from an ex vivo porcine left ventricular wall. These simulation methods provide insight for optimizing our measurement methods for in vivo characterization of material properties.
Improving Spiritual Well-Being in Patients with Lung Cancers
Piderman, Katherine M. , Sytsma, Terin T. , Frost, Marlene H., Novotny, Paul J. , Osian, Sarah M. Rausch, Sloan, Jeff A. , Rummans, Teresa A. , Bronars, Carrie, Clark, Matthew M. , Patten, Christi A. , Bronars, Carrie A, Nes, Lise Solberg , Yang, Ping

Mayo Clinic

Journal of Pastoral Care & Counseling: Advancing theory and professional practice through scholarly and reflective publicati | October 13, 2015 | Volume: 69 | Issue: 3 | Pages: 156-162

10.1177/1542305015602711 | PMID 26463853 Get It

Patients with lung cancer report more disease burden and lower spiritual well-being (SWB) compared with other cancer patients. Understanding variables that lessen disease burden and improve SWB is essential. The aim of this study was to explore the relationship between motivational level for physical activity and SWB in patients with lung cancer. Linear regression showed increased SWB as stage of change for physical activity increased (p < 0.0001), even after adjusting for multiple demographic variables.
A novel housing-based socioeconomic measure predicts hospitalisation and multiple chronic conditions in a community population
Takahashi, Paul Y. , Ryu, Euijung , Hathcock, Matthew , Bielinski, Suzette J. , Rand-Weaver, Jennifer, Juhn, Young J. , Hathcock, Matthew A, Olson, Janet E. , Cerhan, James R. , Bielinski, Suzette , Takahashi, Paul

Mayo Clinic

Journal of Epidemiology and Community Health | October 13, 2015 | Volume: 70 | Issue: 3 | Pages: 286-291

10.1136/jech-2015-205925 | PMID 26458399 Get It

Background Socioeconomic status (SES) is an important predictor for outcomes of chronic diseases. However, it is often unavailable in clinical data. We sought to determine whether an individual housing-based SES index termed HOUSES can influence the likelihood of multiple chronic conditions (MCC) and hospitalisation in a community population. Methods Participants were residents of Olmsted County, Minnesota, aged >18 years, who were enrolled in Mayo Clinic Biobank on 31 December 2010, with follow-up until 31 December 2011. Primary outcome was all-cause hospitalisation over 1 calendar-year. Secondary outcome was MCC determined through a Minnesota Medical Tiering score. A logistic regression model was used to assess the association of HOUSES with the Minnesota tiering score. With adjustment for age, sex and MCC, the association of HOUSES with hospitalisation risk was tested using the Cox proportional hazards model. Results Eligible patients totalled 6402 persons (median age, 57 years; 25th–75th quartiles, 45–68 years). The lowest quartile of HOUSES was associated with a higher Minnesota tiering score after adjustment for age and sex (OR (95% CI) 2.4 (2.0 to 3.1)) when compared with the highest HOUSES quartile. Patients in the lowest HOUSES quartile had higher risk of all-cause hospitalisation (age, sex, MCC-adjusted HR (95% CI) 1.53 (1.18 to 1.98)) compared with those in the highest quartile. Conclusions Low SES, as assessed by HOUSES, was associated with increased risk of hospitalisation and greater MCC health burden. HOUSES may be a clinically useful surrogate for SES to assess risk stratification for patient care and clinical research.
Multi‐disciplinary antimicrobial strategies for improving orthopaedic implants to prevent prosthetic joint infections in hip and knee
Getzlaf, Matthew A., Lewallen, Eric A. , Kremers, Hilal Maradit , Jones, Dakota L. , Bonin, Carolina A. , Dudakovic, Amel , Thaler, Roman , Cohen, Robert C., Lewallen, David G. , Wijnen, André J. van , Kremers, Hilal M, van Wijnen, Andre J, van Wijnen, Andre J , Maradit Kremers, Hilal

Mayo Clinic

Journal of Orthopaedic Research | October 9, 2015 | Volume: 34 | Issue: 2 | Pages: 177-186

10.1002/jor.23068 | PMID 26449208 Get It

ABSTRACTLike any foreign object, orthopaedic implants are susceptible to infection when introduced into the human body. Without additional preventative measures, the absolute number of annual prosthetic joint infections will continue to rise, and may exceed the capacity of health care systems in the near future. Bacteria are difficult to eradicate from synovial joints due to their exceptionally diverse taxonomy, complex mechanistic attachment capabilities, and tendency to evolve antibiotic resistance. When a primary orthopaedic implant fails from prosthetic joint infection, surgeons are generally challenged by limited options for intervention. In this review, we highlight the etiology and taxonomic groupings of bacteria known to cause prosthetic joint infections, and examine their key mechanisms of attachment. We propose that antimicrobial strategies should focus on the most harmful bacteria taxa within the context of occurrence, taxonomic diversity, adhesion mechanisms, and implant design. Patient‐specific identification of organisms that cause prosthetic joint infections will permit assessment of their biological vulnerabilities. The latter can be targeted using a range of antimicrobial techniques that exploit different colonization mechanisms including implant surface attachment, biofilm formation, and/or hematogenous recruitment. We anticipate that customized strategies for each patient, joint, and prosthetic component will be most effective at reducing prosthetic joint infections, including those caused by antibiotic‐resistant and polymicrobial bacteria. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:177–186, 2016.